BerganKDV Wealth Management’s West Pharmaceutical WST Stock Holding History

BerganKDV Wealth Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$64.3K	Sell	168 -16	-9%	-$5.72K	0.01%	353
2023 Q1	$63.8K	Hold	184	–	–	0.01%	363
2022 Q4	$43.3K	Sell	184 -3	-2%	-$711	﹤0.01%	390
2022 Q3	$46K	Buy	187 +168	+884%	+$51.2K	0.01%	381
2022 Q2	$6K	Hold	19	–	–	﹤0.01%	683
2022 Q1	$8K	Sell	19 -14	-42%	-$5.48K	﹤0.01%	654
2021 Q4	$15K	Buy	33 +14	+74%	+$6.03K	﹤0.01%	592
2021 Q3	$8K	Hold	19	–	–	﹤0.01%	683
2021 Q2	$7K	Hold	19	–	–	﹤0.01%	666
2021 Q1	$5K	Hold	19	–	–	﹤0.01%	678
2020 Q4	$5K	Sell	19 -11	-37%	-$3.09K	﹤0.01%	671
2020 Q3	$8K	Hold	30	–	–	﹤0.01%	539
2020 Q2	$7K	Sell	30 -11	-27%	-$2.16K	﹤0.01%	597
2020 Q1	$6K	Buy	41 +11	+37%	+$1.69K	﹤0.01%	569
2019 Q4	$5K	Buy	+30	New	+$4.37K	﹤0.01%	634

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

BerganKDV Wealth Management's WST Position: Q2 2023 in Review

BerganKDV Wealth Management reduced its West Pharmaceutical (WST) stake by 8.7% in Q2 2023, selling an estimated $5.72K and leaving 168 shares worth $64.3K. The position accounts for 0.01% of the portfolio, ranked #353.

BerganKDV Wealth Management first reported a position in WST in Q4 2019 and has held it in 15 quarters since. 734 funds tracked by Wall St. Rank hold WST as of Q2 2023.

BerganKDV Wealth Management held 168 shares of West Pharmaceutical worth $64.3K as of Q2 2023.
BerganKDV Wealth Management sold 16 West Pharmaceutical shares in Q2 2023, an estimated $5.72K.
West Pharmaceutical made up 0.01% of BerganKDV Wealth Management's portfolio in Q2 2023, its #353 holding.
BerganKDV Wealth Management first reported a position in West Pharmaceutical in Q4 2019 and has held it in 15 quarters since.
734 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.